IV Thrombolysis Offers No Benefit for Mild Stroke

BASEL, SWITZERLAND — Minor ischemic stroke patients with intracranial occlusion should not be treated with IV thrombolysis, a new trial has concluded. Results from the randomized controlled trial TEMPO-2 showed no benefit from treatment with tenecteplase following ischemic stroke. In addition, investigators found a small increased risk for symptomatic intracranial hemorrhage (ICH) and more deaths …

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button